APA (7th ed.) Citation

Roberta Venturella, Tomasz Rechberger, János Zatik, Rachel B. Wagman, Emily Zhu, Viatcheslav G. Rakov, & Felice Petraglia. (2023). Relugolix combination therapy in European women with symptomatic uterine fibroids: A subgroup analysis from the randomized phase 3 LIBERTY pivotal trials. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Roberta Venturella, Tomasz Rechberger, János Zatik, Rachel B. Wagman, Emily Zhu, Viatcheslav G. Rakov, and Felice Petraglia. Relugolix Combination Therapy in European Women with Symptomatic Uterine Fibroids: A Subgroup Analysis from the Randomized Phase 3 LIBERTY Pivotal Trials. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

Roberta Venturella, et al. Relugolix Combination Therapy in European Women with Symptomatic Uterine Fibroids: A Subgroup Analysis from the Randomized Phase 3 LIBERTY Pivotal Trials. Taylor & Francis Group, 2023.